Thirdeye Systems Ltd. Logo

Thirdeye Systems Ltd.

Develops AI object recognition algorithms and hardware for the thermal spectrum.

THES | TA

Overview

Corporate Details

ISIN(s):
IL0003970188
LEI:
Country:
Israel
Address:
8 Ha-Melakha St., 4250543 Netanya

Description

Thirdeye Systems Ltd. is a research and development company specializing in high-end, AI-powered object recognition algorithms, with a primary focus on the thermal spectrum. The company develops solutions that leverage deep neural networks and fuse thermal with visible light imaging to enable advanced perception. Its product portfolio includes both software analytics that can be integrated into third-party electro-optical/infrared (EO/IR) systems and complete hardware payloads. These systems are designed for applications such as counter-drone (C-UAV) security, perception for unmanned ground vehicles (UGV), and aerial surveillance. The technology provides real-time, automatic detection, classification, and tracking of objects like drones, vehicles, and humans in various operational conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-09-13 16:38
Opening of Trading On September 14 2022- THIRDEYE W2, THIRDEYE W3
Hebrew (modern) 176.1 KB
2022-09-12 16:03
Identifying Details of New Securities-THIRDEYE W2, THIRDEYE W3
Hebrew (modern) 89.2 KB
2022-05-01 11:29
Company's Presentation-May 2022
Hebrew (modern) 1.7 MB
2022-05-01 11:29
Company's Presentation-May 2022
Russian 42.6 KB
2021-06-03 14:17
Discontinuation of Market Making
Hebrew (modern) 186.2 KB
2021-05-20 20:31
On June 3th, 2021, following seasoned shares will be added to the respective in…
Hebrew (modern) 333.6 KB
2021-05-13 15:52
Changes in company's and securities names effective of May 18, 2021
Hebrew (modern) 149.3 KB
2021-04-12 10:25
change the sector classification of the company from - - REAL-ESTATE & CONSTRUC…
Hebrew (modern) 148.1 KB
2021-02-01 18:38
On February 2, 2021, the company's securities will be transferred from the main…
Hebrew (modern) 150.0 KB

Automate Your Workflow. Get a real-time feed of all Thirdeye Systems Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Thirdeye Systems Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Thirdeye Systems Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NGeneBio Co., Ltd. Logo
Develops NGS-based molecular diagnostic products and software for oncology.
South Korea
354200
Nicox S.A. Logo
Ophthalmology company developing therapies based on a nitric oxide-donating platform.
France
COX
NLS Pharmaceutics Ltd. Logo
Clinical-stage biopharma firm developing therapies for rare and complex CNS disorders.
United States of America
NLSP
NovoCure Ltd Logo
Develops a non-invasive cancer therapy using electric fields to disrupt solid tumors.
United States of America
NVCR
NUFORMIX PLC Logo
Pharmaceutical developer using cocrystal technology to repurpose drugs for fibrosis.
United Kingdom
NFX
Nurix Therapeutics, Inc. Logo
Clinical-stage biopharma developing protein degradation therapies for various diseases.
United States of America
NRIX
OLIPASS CORPORATION Logo
An R&D company developing RNA therapeutics using its proprietary OPNA platform.
South Korea
244460
A technology platform for therapeutic antibody discovery using transgenic animals.
United States of America
OABIW
ONCIMMUNE HOLDINGS PLC Logo
Immunodiagnostics company specializing in antibody and autoantibody biomarker signatures.
United Kingdom
ONC
Oncocross Co.,Ltd. Logo
An AI biotechnology firm that develops drugs by predicting drug-disease interactions.
South Korea
382150

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.